Literature DB >> 27616589

PI3Kδ and primary immunodeficiencies.

Carrie L Lucas1,2, Anita Chandra3,4, Sergey Nejentsev4, Alison M Condliffe5, Klaus Okkenhaug3.   

Abstract

Primary immunodeficiencies are inherited disorders of the immune system, often caused by the mutation of genes required for lymphocyte development and activation. Recently, several studies have identified gain-of-function mutations in the phosphoinositide 3-kinase (PI3K) genes PIK3CD (which encodes p110δ) and PIK3R1 (which encodes p85α) that cause a combined immunodeficiency syndrome, referred to as activated PI3Kδ syndrome (APDS; also known as p110δ-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency (PASLI)). Paradoxically, both loss-of-function and gain-of-function mutations that affect these genes lead to immunosuppression, albeit via different mechanisms. Here, we review the roles of PI3Kδ in adaptive immunity, describe the clinical manifestations and mechanisms of disease in APDS and highlight new insights into PI3Kδ gleaned from these patients, as well as implications of these findings for clinical therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27616589      PMCID: PMC5291318          DOI: 10.1038/nri.2016.93

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  89 in total

Review 1.  Molecules in medicine mini-review: isoforms of PI3K in biology and disease.

Authors:  Bart Vanhaesebroeck; Maria A Whitehead; Roberto Piñeiro
Journal:  J Mol Med (Berl)       Date:  2015-12-10       Impact factor: 4.599

2.  A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia.

Authors:  Susan M O'Brien; Nicole Lamanna; Thomas J Kipps; Ian Flinn; Andrew D Zelenetz; Jan A Burger; Michael Keating; Siddhartha Mitra; Leanne Holes; Albert S Yu; David M Johnson; Langdon L Miller; Yeonhee Kim; Roger D Dansey; Ronald L Dubowy; Steven E Coutre
Journal:  Blood       Date:  2015-10-15       Impact factor: 22.113

3.  Activating PI3Kδ mutations in a cohort of 669 patients with primary immunodeficiency.

Authors:  M Elgizouli; D M Lowe; C Speckmann; D Schubert; J Hülsdünker; Z Eskandarian; A Dudek; A Schmitt-Graeff; J Wanders; S F Jørgensen; B Fevang; U Salzer; A Nieters; S Burns; B Grimbacher
Journal:  Clin Exp Immunol       Date:  2015-11-09       Impact factor: 4.330

4.  Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation.

Authors:  Baher F Nashed; Tingting Zhang; Monther Al-Alwan; Ganesh Srinivasan; Andrew J Halayko; Klaus Okkenhaug; Bart Vanhaesebroeck; Kent T Hayglass; Aaron J Marshall
Journal:  Eur J Immunol       Date:  2007-02       Impact factor: 5.532

5.  The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment.

Authors:  Maria Chiriaco; Immacolata Brigida; Paola Ariganello; Silvia Di Cesare; Gigliola Di Matteo; Francesco Taus; Davide Cittaro; Dejan Lazarevic; Alessia Scarselli; Veronica Santilli; Enrico Attardi; Elia Stupka; Stefania Giannelli; Maurizio Fraziano; Andrea Finocchi; Paolo Rossi; Alessandro Aiuti; Paolo Palma; Caterina Cancrini
Journal:  Clin Immunol       Date:  2015-12-28       Impact factor: 3.969

Review 6.  Activated PI3Kδ syndrome type 2: Two patients, a novel mutation, and review of the literature.

Authors:  Peter Olbrich; Myriam Lorenz; Paola Cura Daball; José Manuel Lucena; Anne Rensing-Ehl; Berta Sanchez; Marita Führer; Marisol Camacho-Lovillo; Marta Melon; Klaus Schwarz; Olaf Neth; Carsten Speckmann
Journal:  Pediatr Allergy Immunol       Date:  2016-05-27       Impact factor: 6.377

7.  Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase.

Authors:  Mathieu Gigoux; Jijun Shang; Youngshil Pak; Minghong Xu; Jongseon Choe; Tak W Mak; Woong-Kyung Suh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-13       Impact factor: 11.205

8.  Novel Foxo1-dependent transcriptional programs control T(reg) cell function.

Authors:  Weiming Ouyang; Will Liao; Chong T Luo; Na Yin; Morgan Huse; Myoungjoo V Kim; Min Peng; Pamela Chan; Qian Ma; Yifan Mo; Dies Meijer; Keji Zhao; Alexander Y Rudensky; Gurinder Atwal; Michael Q Zhang; Ming O Li
Journal:  Nature       Date:  2012-11-07       Impact factor: 49.962

9.  Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells.

Authors:  Daniel T Patton; Oliver A Garden; Wayne P Pearce; Louise E Clough; Clare R Monk; Eva Leung; Wendy C Rowan; Sara Sancho; Lucy S K Walker; Bart Vanhaesebroeck; Klaus Okkenhaug
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

Review 10.  Synergy in activating class I PI3Ks.

Authors:  John E Burke; Roger L Williams
Journal:  Trends Biochem Sci       Date:  2015-01-05       Impact factor: 13.807

View more
  94 in total

1.  Dysregulated actin dynamics in activated PI3Kδ syndrome.

Authors:  Jacqueline G Wallace; Pedro Zambrano-Rodas; Wilmer Córdova-Calderón; Santiago Estrada-Turriate; Daniel Mendoza-Quispe; Yesenia Limache Ontiveros; Raif S Geha; Janet Chou; Craig D Platt
Journal:  Clin Immunol       Date:  2019-11-21       Impact factor: 3.969

2.  Hematopoietic stem cell transplantation for activated phosphoinositide 3-kinase δ syndrome: Who, when, and how?

Authors:  Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2018-09-12       Impact factor: 10.793

3.  PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia.

Authors:  Bola S Hanna; Philipp M Roessner; Annika Scheffold; Billy M C Jebaraj; Yasmin Demerdash; Selcen Öztürk; Peter Lichter; Stephan Stilgenbauer; Martina Seiffert
Journal:  Leukemia       Date:  2018-12-20       Impact factor: 11.528

4.  Immunodeficiency, autoimmune thrombocytopenia and enterocolitis caused by autosomal recessive deficiency of PIK3CD-encoded phosphoinositide 3-kinase δ.

Authors:  David J Swan; Dominik Aschenbrenner; Christopher A Lamb; Krishnendu Chakraborty; Jonathan Clark; Sumeet Pandey; Karin R Engelhardt; Rui Chen; Athena Cavounidis; Yuchun Ding; Natalio Krasnogor; Christopher D Carey; Meghan Acres; Stephanie Needham; Andrew J Cant; Peter D Arkwright; Anita Chandra; Klaus Okkenhaug; Holm H Uhlig; Sophie Hambleton
Journal:  Haematologica       Date:  2019-05-09       Impact factor: 9.941

Review 5.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

6.  Thyroid Carcinoma in a Child with Activated Phosphoinositide 3-Kinase δ Syndrome: Somatic Effect of a Germline Mutation.

Authors:  Giorgia Bucciol; Lien Willems; Esther Hauben; Anne Uyttebroeck; Marijke Proesmans; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2017-06-11       Impact factor: 8.317

Review 7.  Emerging insights into human health and NK cell biology from the study of NK cell deficiencies.

Authors:  Emily M Mace; Jordan S Orange
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

8.  Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors.

Authors:  Klemens Hoegenauer; Nicolas Soldermann; Frédéric Zécri; Ross S Strang; Nadege Graveleau; Romain M Wolf; Nigel G Cooke; Alexander B Smith; Gregory J Hollingworth; Joachim Blanz; Sascha Gutmann; Gabriele Rummel; Amanda Littlewood-Evans; Christoph Burkhart
Journal:  ACS Med Chem Lett       Date:  2017-08-25       Impact factor: 4.345

9.  Mutations in PI3K110δ cause impaired natural killer cell function partially rescued by rapamycin treatment.

Authors:  Raquel Ruiz-García; Alexander Vargas-Hernández; Ivan K Chinn; Laura S Angelo; Tram N Cao; Zeynep Coban-Akdemir; Shalini N Jhangiani; Qingchang Meng; Lisa R Forbes; Donna M Muzny; Luis M Allende; Mohammed S Ehlayel; Richard A Gibbs; James R Lupski; Gulbu Uzel; Jordan S Orange; Emily M Mace
Journal:  J Allergy Clin Immunol       Date:  2018-01-10       Impact factor: 10.793

10.  Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohort.

Authors:  Qinchuan Wang; Justin R Gregg; Jian Gu; Yuanqing Ye; David W Chang; John W Davis; Timothy C Thompson; Jeri Kim; Christopher J Logothetis; Xifeng Wu
Journal:  Oncoimmunology       Date:  2018-10-29       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.